Brief: Axcelead Drug Discovery Partners Enters Into Master Service Agreement For Drug Discovery Projects With Acadia Pharmaceuticals
Sept 19 (Reuters) - AXCELEAD:
* AXCELEAD DRUG DISCOVERY PARTNERS ENTERS INTO MASTER
SERVICE
AGREEMENT FOR DRUG DISCOVERY PROJECTS WITH ACADIA
PHARMACEUTICALS
* AXCELEAD DRUG DISCOVERY PARTNERS: DETAILS OF FINANCIAL
TERMS
REGARDING MASTER SERVICE AGREEMENT AND NEW PROJECT ARE NOT
DISCLOSED
Source text for Eikon: ID:nBw1mm9Dma
Further company coverage: ACAD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Acadia Pharmaceuticals
See all newsUS RESEARCH ROUNDUP-Chevron, Exxon Mobil, GoDaddy
U.S. STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
US STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
Acadia's Alzheimer's psychosis drug misses main goal of mid-stage study (updated)
U.S. STOCKS ON THE MOVE-CoreWeave, Versant Media, BlackBerry